• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC NAVIGATION, INC MEDTRONIC NAVIGATION; POWERED LASER SURGICAL INSTRUMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC NAVIGATION, INC MEDTRONIC NAVIGATION; POWERED LASER SURGICAL INSTRUMENT Back to Search Results
Model Number UNK_VISUALASE_SYS
Device Problems Material Fragmentation (1261); Biocompatibility (2886)
Patient Problems Intracranial Hemorrhage (1891); Paresis (1998); Loss of Vision (2139); Paresthesia (4421); Unspecified Nervous System Problem (4426)
Event Date 05/08/2021
Event Type  Injury  
Manufacturer Narrative
This value is the average age of the patients reported in the article as specific patients could not be identified.This value reflects the gender of the majority of the patients reported in the article as specific patients could not be identified.Please note that this date is based off of the date the article was accepted for publication as the event dates were not provided in the published literature.No parts have been received by the manufacturer for evaluation.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Malcolm, j.G., miller douglas, j., greven, a., rich, c., dawoud, r.A., hu, r., reisner, a., barrow, d.L., gross, r.E., willie, j.T.Feasibility and morbidity of magnetic resonance imaging-guided stereotactic laser ablation of deep cerebral cavernous malformations: a report of 4 cases.Neurosurgery 0:1¿10, 2021 https://doi.Org/10.1093/neuros/nyab241 background: magnetic resonance imaging (mri)-guided laser interstitial thermal therapy (mrglitt) has been used successfully to treat epileptogenic cortical cerebral cavernous malformations (ccm).It is unclear whether mrglitt would be as feasible or safe for deep ccms objective: to describe our experience with mrglitt for symptomatic deep ccms methods: patients¿ records were reviewed retrospectively.Mrglitt was carried out using a commercially available system in an interventional mri suite with efforts to protect adjacent brain structures.Immediate postoperative imaging was used to judge ablation adequacy.Delayed postoperative mri was used to measure lesion volume changes during follow-up.Results: four patients with ccm in the thalamus, putamen, midbrain, or subthalamus presented with persistent and disabling neurological symptoms.A total of 2 patients presented with disabling headaches and sensory disturbances and 2 with recurrent symptomatic hemorrhages, of which 1 had familial ccm.Patients were considered by vascular neurosurgeons to be poor candidates for open surgery or had refused it.Multiple trajectories were used in most cases.Adverse events included device malfunction with leakage of saline causing transient mass effect in one patient, and asymptomatic tract hemorrhage in another.One patient suffered an expected mild but persistent exacerbation of baseline deficits.All patients showed improvement from a previously aggressive clinical course with lesion volume decreased by 20% to 73% in follow-up.Conclusion: mrglitt is feasible in the treatment of symptomatic deep ccm but may carry a high risk of complications without the benefit of definitive resection.We recommend cautious patient selection, low laser power settings, and conservative temperature monitoring in surrounding brain parenchyma.Reportable events: 1 patient who was 27 years old had a perioperative mild parasthesia.During 1 patients procedure, who was 41 years old, had the device malfunction causing a saline leakage into the brain.Which caused an incomplete ablation, transient upper extremity apraxia and transient left hemiparesis.Also the device top melted due to high laser energy.1 patient who was 14 years old had 2 persistent exacerbation of hemiparesis and hemianopia 1 patient who was 62 years old had a small asymptomatic tract hemorrhage see attached literature article.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MEDTRONIC NAVIGATION
Type of Device
POWERED LASER SURGICAL INSTRUMENT
Manufacturer (Section D)
MEDTRONIC NAVIGATION, INC
826 coal creek circle
louisville CO 80027
Manufacturer (Section G)
MEDTRONIC NAVIGATION, INC
826 coal creek circle
louisville CO 80027
Manufacturer Contact
david gustafson
7000 central avenue ne rcw215
minneapolis, MN 55432
7635149628
MDR Report Key12433107
MDR Text Key270271765
Report Number1723170-2021-02210
Device Sequence Number1
Product Code GEX
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K081656
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,literatur
Reporter Occupation Other
Type of Report Initial
Report Date 09/07/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberUNK_VISUALASE_SYS
Device Catalogue NumberUNK_VISUALASE_SYS
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 08/17/2021
Initial Date FDA Received09/07/2021
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age36 YR
-
-